SCHEMBL11888024

SCHEMBL11888024

CCc1cc(C(=O)OC)sc1NC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.44
MAPK1 P28482 4/20 0.44
NPSR1 Q6W5P4 3/20 0.44
TSHR P16473 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ATM Q13315 1/20 0.44
ALDH1A1 P00352 7/20 0.40
KDM4E B2RXH2 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 1/20 0.40
CSNK2A2 P19784 1/20 0.39
KDR P35968 1/20 0.39
CSNK2B P67870 1/20 0.39
CSNK2A1 P68400 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 1/20 0.38
OPRD1 P41143 1/20 0.38
HSD17B10 Q99714 5/20 0.38
LMNA P02545 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19049035 0.79 ALDH1A1 (0.54) HPGDMAPK1NPSR1TSHRL3MBTL1
SCHEMBL15080340 0.79 CSNK2A2 (0.44) HPGDMAPK1NPSR1TSHRL3MBTL1
SCHEMBL18420119 0.79 HPGD (0.46) HPGDMAPK1NPSR1TSHRL3MBTL1
SCHEMBL24577254 0.77 HPGD (0.45) HPGDMAPK1NPSR1TSHRL3MBTL1
SCHEMBL24578190 0.72 USP10 (0.43) HPGDMAPK1NPSR1TSHRL3MBTL1
SCHEMBL19002552 0.71 ALDH1A1 (0.43) HPGDMAPK1NPSR1TSHRL3MBTL1
SCHEMBL16901555 0.70 HPGD (0.54) HPGDMAPK1NPSR1TSHRL3MBTL1
SCHEMBL12271839 0.70 L3MBTL1 (0.42) HPGDMAPK1NPSR1TSHRL3MBTL1
SCHEMBL26743180 0.70 HPGD (0.39) HPGDMAPK1NPSR1TSHRL3MBTL1
SCHEMBL16639425 0.70 HPGD (0.42) HPGDMAPK1NPSR1TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8227605-B2 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors SCHERING CORPORATION (US) 2012-07-24 US disclosed
US-20100055090-A1 2-AMINOTHIAZOLE-4-CARBOXYLIC AMIDES AS PROTEIN KINASE INHIBITORS MERCK SHARP & DOHME LLC 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100055090-A1 2-AMINOTHIAZOLE-4-CARBOXYLIC AMIDES AS PROTEIN KINASE INHIBITORS MAPK15, CDK15, MAP3K15 HPGD 3349/4885MAPK1 50/4885NPSR1 1987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.